Sarepta Therapeutics SRPT spent $180K on lobbying in Q4 2022 · Health Issues, Taxation

Trade details

Type: Lobbying report
Amount: $180,000
Quarter: Q4 2022
Stock: Sarepta Therapeutics SRPT
Client: Sarepta Therapeutics
Reported: 23/01/19

$280K on lobbying in 2022

What else happened in Sarepta Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Sarepta Therapeutics's other lobbying reports

Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$90K
$90K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1

Sarepta Therapeutics SRPT spent $180K on lobbying in Q4 2022 · Health Issues, Taxation | Whalegun